TRELLUS HEALTH PLC (TRLS) — Full Year Results

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the TRELLUS HEALTH PLC investor presentation. Throughout the recorded presentation, investors will be in listen only mode. Questions are encouraged, they can be submitted at any time by the q and a tab situated in the right hand corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question received in the meeting itself. However, the company can review all the questions submitted today and publish responses as appropriate to do so. Before we begin, I'd like to make the following poll. I'd now like to hand you to CEO, Marla Dubinsky. Good morning. Good morning. Thank you so much, and welcome everybody, to the investor meet for TRLS Health, our 2024 annual results. And I'm accompanied today by our CFO, Joy Bessinger. Good morning, everybody. Right. So let's move forward. So here's our disclaimer slide. So to level set, I just wanna remind everybody sort of what TRLS and what our purpose and how we were built for scale. TRLS HEALTH is a healthcare company that's transforming the chronic condition management space through our proprietary resilience platform, which really is our differentiator with the goal of improving patient outcomes, reduce the cost of care, and really drive value across our three key partners, which are in the clinical trial space, pharma, manufacturers, as well as pharmacy distribution, and health plans. As I noted, our key differentiator really is our proprietary platform that is solely built and intended to improve people's engagements in their health, improve the adherence to these chronic, medications that individuals with these conditions need in order to, manage their condition because there is no cure and deliver better outcomes, and value. ...